Thanks to an agreement between the Royal Netherlands Academy of Arts and Sciences (KNAW) and Oncode Institute, the organoid technology will become available to all 800+ cancer researchers that are part of Oncode. The KNAW collaborates with its institutional partner UMC Utrecht on organoid technology. Thanks to this agreement with Oncode, researchers receive a license to conduct research on organoids for the first time in the Netherlands.
Growing and researching organoids is a technology developed by Oncode researcher Hans Clevers. Clevers works - among others - at the Hubrecht Institute (KNAW) and the UMC Utrecht and is a professor at Utrecht University. The KNAW manages the licenses for the use of this technology together with UMC Utrecht. For the quality of cancer research, it is a unique step that unlimited research for academic purposes is now possible. The use of organoids allows researchers to analyze tumor growth with limited amounts of tissue from patients, to investigate genetic instability and to test new drug combinations. Cancer researchers who are not affiliated with Oncode that are interested to use this technology can contact KNAW.